HALOZYME THERAPEUTICS, INC. Debt Instrument, Periodic Payment, Interest
HALOZYME THERAPEUTICS, INC. (HALO) reported Debt Instrument, Periodic Payment, Interest of $5.80 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-23.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentPeriodicPaymentInterest · last filed 2021-02-23
- HALOZYME THERAPEUTICS, INC. debt instrument, periodic payment, interest for fiscal 2020 was $5.80M, a 728.57% increase from fiscal 2019.
- HALOZYME THERAPEUTICS, INC. debt instrument, periodic payment, interest for fiscal 2019 was $700.00K.
| Period end | Debt Instrument, Periodic Payment, Interest 12 month |
|---|---|
| 2020-12-31 | $5.80M 10-K · filed 2021-02-23 |
| 2019-12-31 | $700.00K 10-K · filed 2021-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |